NF‐κB ‐inducing kinase is a key regulator of inflammation‐induced and tumour‐associated angiogenesis
Open Access
- 9 July 2014
- journal article
- research article
- Published by Wiley in The Journal of Pathology
- Vol. 234 (3) , 375-385
Abstract
Angiogenesis is essential during development and in pathological conditions such as chronic inflammation and cancer progression. Inhibition of angiogenesis by targeting vascular endothelial growth factor (VEGF) blocks disease progression, but most patients eventually develop resistance which may result from compensatory signalling pathways. In endothelial cells (ECs), expression of the pro‐angiogenic chemokine CXCL12 is regulated by non‐canonical nuclear factor (NF)‐κB signalling. Here, we report that NF‐κB‐inducing kinase (NIK) and subsequent non‐canonical NF‐κB signalling regulate both inflammation‐induced and tumour‐associated angiogenesis. NIK is highly expressed in endothelial cells (ECs) in tumour tissues and inflamed rheumatoid arthritis synovial tissue. Furthermore, non‐canonical NF‐κB signalling in human microvascular ECs significantly enhanced vascular tube formation, which was completely blocked by siRNA targeting NIK. Interestingly, Nik−/− mice exhibited normal angiogenesis during development and unaltered TNFα‐ or VEGF‐induced angiogenic responses, whereas angiogenesis induced by non‐canonical NF‐κB stimuli was significantly reduced. In addition, angiogenesis in experimental arthritis and a murine tumour model was severely impaired in these mice. These studies provide evidence for a role of non‐canonical NF‐κB signalling in pathological angiogenesis, and identify NIK as a potential therapeutic target in chronic inflammatory diseases and tumour neoangiogenesis. © 2014 The Authors. The Journal of Pathology published by John Wiley & Sons Ltd on behalf of Pathological Society of Great Britain and Ireland.Keywords
Funding Information
- Nederlandse Organisatie voor Wetenschappelijk Onderzoek (91696015)
- Netherlands Organisation for Health Research and Development (90700359)
- Dutch Arthritis Foundation (2012_109)
This publication has 50 references indexed in Scilit:
- NF-κB inhibitor targeted to activated endothelium demonstrates a critical role of endothelial NF-κB in immune-mediated diseasesProceedings of the National Academy of Sciences, 2013
- Use of the mouse aortic ring assay to study angiogenesisNature Protocols, 2011
- The Mouse Retina as an Angiogenesis ModelInvestigative Ophthalmology & Visual Science, 2010
- Expression of COX-2, NF-κB-p65, NF-κB-p50 and IKKα in malignant and adjacent normal human colorectal tissueBritish Journal of Cancer, 2009
- RelB is the NF-κB subunit downstream of NIK responsible for osteoclast differentiationProceedings of the National Academy of Sciences, 2008
- Promiscuous Mutations Activate the Noncanonical NF-κB Pathway in Multiple MyelomaCancer Cell, 2007
- The SDF-1–CXCR4 signaling pathway: a molecular hub modulating neo-angiogenesisTrends in Immunology, 2007
- Angiogenesis in life, disease and medicineNature, 2005
- Neutralization of Vascular Endothelial Growth Factor Prevents Collagen-Induced Arthritis and Ameliorates Established Disease in MiceBiochemical and Biophysical Research Communications, 2001
- Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivoNature, 1993